Sequoia Financial Advisors LLC Takes $436,000 Position in Cabot Corporation $CBT

Sequoia Financial Advisors LLC bought a new stake in shares of Cabot Corporation (NYSE:CBT) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 5,807 shares of the specialty chemicals company’s stock, valued at approximately $436,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CBT. Geneos Wealth Management Inc. lifted its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the last quarter. Banque Cantonale Vaudoise bought a new position in Cabot during the first quarter worth $43,000. CWM LLC lifted its stake in Cabot by 55.0% during the first quarter. CWM LLC now owns 600 shares of the specialty chemicals company’s stock worth $50,000 after purchasing an additional 213 shares during the last quarter. UMB Bank n.a. lifted its stake in Cabot by 52.4% during the second quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock worth $55,000 after purchasing an additional 251 shares during the last quarter. Finally, Brooklyn Investment Group lifted its stake in Cabot by 1,553.7% during the first quarter. Brooklyn Investment Group now owns 678 shares of the specialty chemicals company’s stock worth $56,000 after purchasing an additional 637 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on CBT shares. UBS Group set a $82.00 price objective on Cabot and gave the stock a “neutral” rating in a research note on Tuesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Wednesday, October 8th. Finally, Mizuho cut their target price on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research note on Friday, October 3rd. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $85.00.

Insider Activity at Cabot

In other news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the transaction, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.03% of the company’s stock.

Cabot Stock Performance

CBT stock opened at $70.64 on Tuesday. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of 9.23 and a beta of 0.88. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. Cabot Corporation has a 1 year low of $66.50 and a 1 year high of $117.46. The stock’s fifty day moving average is $77.19 and its two-hundred day moving average is $76.60.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. The company had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, research analysts predict that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.